More on CERS
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Product revenue | 10.18M |
| Government grants and cooperative agreements | |
| Total revenue | |
| Cost of product revenue | 5.45M |
| Gross profit | 4.72M |
| Research and development | |
| Selling, general and administrative | 12.16M |
| Amortization of intangible assets | 50K |
| Acquisition related costs, net | |
| Total operating expenses | 19.24M |
| Loss from operations | -14.26M |
| Loss from revaluation of warrant liability | |
| Foreign exchange gain (loss) | -61K |
| Interest expense | -586K |
| Other expense, net | 114K |
| Total non-operating expense | -533K |
| Net loss | -14.38M |
| Basic | -0.14 |
| Diluted | -0.14 |
| Basic | 102.77M |
| Diluted | 102.77M |
Entities mentioned with CERS
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Robert W Baird | View Related Stories »
- BTIG | View Related Stories »
- Show More...
